nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—NISCH—midbrain—nicotine dependence	0.0202	0.08	CbGeAlD
Oxymetazoline—HTR1E—brain—nicotine dependence	0.0173	0.0685	CbGeAlD
Oxymetazoline—HTR1B—cardiovascular system—nicotine dependence	0.0167	0.066	CbGeAlD
Oxymetazoline—HTR1D—cardiovascular system—nicotine dependence	0.0162	0.0639	CbGeAlD
Oxymetazoline—HTR2B—cardiovascular system—nicotine dependence	0.015	0.0595	CbGeAlD
Oxymetazoline—HTR1B—midbrain—nicotine dependence	0.013	0.0516	CbGeAlD
Oxymetazoline—NISCH—brain—nicotine dependence	0.0127	0.0503	CbGeAlD
Oxymetazoline—HTR1D—midbrain—nicotine dependence	0.0126	0.0499	CbGeAlD
Oxymetazoline—HTR2C—midbrain—nicotine dependence	0.0125	0.0494	CbGeAlD
Oxymetazoline—ADRA1A—cardiovascular system—nicotine dependence	0.0124	0.0491	CbGeAlD
Oxymetazoline—ADRA1B—brain—nicotine dependence	0.0108	0.0429	CbGeAlD
Oxymetazoline—ADRA1D—brain—nicotine dependence	0.0106	0.042	CbGeAlD
Oxymetazoline—ADRA2C—midbrain—nicotine dependence	0.00924	0.0365	CbGeAlD
Oxymetazoline—HTR1B—brain—nicotine dependence	0.00819	0.0324	CbGeAlD
Oxymetazoline—HTR2A—cardiovascular system—nicotine dependence	0.00803	0.0317	CbGeAlD
Oxymetazoline—HTR1D—brain—nicotine dependence	0.00793	0.0314	CbGeAlD
Oxymetazoline—HTR2C—brain—nicotine dependence	0.00785	0.0311	CbGeAlD
Oxymetazoline—HTR2B—brain—nicotine dependence	0.00738	0.0292	CbGeAlD
Oxymetazoline—ADRA2A—midbrain—nicotine dependence	0.00737	0.0292	CbGeAlD
Oxymetazoline—HTR2A—midbrain—nicotine dependence	0.00627	0.0248	CbGeAlD
Oxymetazoline—ADRA1A—brain—nicotine dependence	0.00609	0.0241	CbGeAlD
Oxymetazoline—ADRA2C—brain—nicotine dependence	0.00581	0.023	CbGeAlD
Oxymetazoline—ADRA2A—brain—nicotine dependence	0.00463	0.0183	CbGeAlD
Oxymetazoline—HTR2A—brain—nicotine dependence	0.00394	0.0156	CbGeAlD
Oxymetazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00258	0.00346	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00258	0.00346	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00258	0.00346	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00258	0.00345	CbGpPWpGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00253	0.00339	CbGpPWpGaD
Oxymetazoline—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00251	0.00336	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00243	0.00325	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.0024	0.00321	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00238	0.00318	CbGpPWpGaD
Oxymetazoline—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.00235	0.00315	CbGpPWpGaD
Oxymetazoline—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00235	0.00314	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00235	0.00314	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00233	0.00312	CbGpPWpGaD
Oxymetazoline—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.0023	0.00308	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00226	0.00302	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00224	0.003	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00221	0.00296	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.0022	0.00295	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00218	0.00292	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00218	0.00291	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00214	0.00287	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00214	0.00286	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR ligand binding—DRD2—nicotine dependence	0.0021	0.00281	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TAS2R16—nicotine dependence	0.00209	0.00279	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00207	0.00277	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00205	0.00274	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00204	0.00273	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00203	0.00271	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00201	0.00268	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.002	0.00267	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00197	0.00263	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00196	0.00262	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00194	0.0026	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00193	0.00258	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00192	0.00257	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00191	0.00255	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.0019	0.00255	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0019	0.00255	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0019	0.00255	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.00188	0.00252	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00187	0.00251	CbGpPWpGaD
Oxymetazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00187	0.0025	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00187	0.0025	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00187	0.0025	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00185	0.00248	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.00184	0.00246	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00184	0.00246	CbGpPWpGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00183	0.00245	CbGpPWpGaD
Oxymetazoline—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00182	0.00243	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00181	0.00242	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00178	0.00238	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00177	0.00237	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00177	0.00237	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00173	0.00231	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.00173	0.00231	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00172	0.0023	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.0017	0.00228	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0017	0.00228	CbGpPWpGaD
Oxymetazoline—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.0017	0.00227	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00169	0.00226	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00168	0.00225	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00167	0.00223	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00166	0.00223	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—OPRM1—nicotine dependence	0.00164	0.0022	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—FGD1—nicotine dependence	0.00164	0.00219	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00163	0.00218	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00162	0.00217	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00161	0.00215	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.0016	0.00214	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0016	0.00214	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00157	0.00211	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00155	0.00207	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00155	0.00207	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00154	0.00207	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00154	0.00206	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00152	0.00204	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00152	0.00203	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00151	0.00202	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00149	0.002	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—OPRM1—nicotine dependence	0.00149	0.00199	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00147	0.00197	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00146	0.00195	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00145	0.00194	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKR1B10—nicotine dependence	0.00145	0.00194	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00144	0.00193	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.00142	0.0019	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00142	0.0019	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00142	0.00189	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00141	0.00188	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.0014	0.00188	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.0014	0.00187	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.0014	0.00187	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.00139	0.00186	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00139	0.00186	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00139	0.00185	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00138	0.00184	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00138	0.00184	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.00136	0.00182	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00135	0.0018	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.00134	0.00179	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00133	0.00179	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00133	0.00178	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.00131	0.00175	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00131	0.00175	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.0013	0.00174	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00128	0.00171	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00127	0.0017	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00124	0.00166	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.00122	0.00163	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00121	0.00162	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00121	0.00162	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00121	0.00162	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0012	0.00161	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.00119	0.00159	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—DRD2—nicotine dependence	0.00119	0.00159	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00118	0.00158	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00115	0.00154	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.00111	0.00149	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.00111	0.00149	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.0011	0.00148	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.0011	0.00147	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0011	0.00147	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00109	0.00146	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00109	0.00146	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.00109	0.00146	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—DRD2—nicotine dependence	0.00108	0.00144	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.00106	0.00141	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00105	0.00141	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.00103	0.00137	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00102	0.00137	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00102	0.00137	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.00102	0.00137	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—WASF2—nicotine dependence	0.00102	0.00136	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.00101	0.00135	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.00101	0.00135	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00101	0.00135	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000989	0.00132	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000981	0.00131	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—WASF1—nicotine dependence	0.000978	0.00131	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000961	0.00129	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000952	0.00127	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000951	0.00127	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000929	0.00124	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000917	0.00123	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000912	0.00122	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000902	0.00121	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000898	0.0012	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000893	0.0012	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	0.00088	0.00118	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000864	0.00116	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000859	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000858	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.00084	0.00112	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000834	0.00112	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00083	0.00111	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000825	0.0011	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000824	0.0011	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000804	0.00108	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000803	0.00107	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000802	0.00107	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00079	0.00106	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000789	0.00106	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000787	0.00105	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000787	0.00105	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00078	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000758	0.00101	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000749	0.001	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.00074	0.00099	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.00073	0.000977	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000729	0.000976	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000728	0.000974	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000717	0.00096	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000717	0.000959	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000716	0.000958	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.000715	0.000957	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000708	0.000948	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000702	0.000939	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000701	0.000938	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000697	0.000933	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.000691	0.000925	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000688	0.000921	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.000677	0.000906	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.000672	0.000899	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.000663	0.000887	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000652	0.000873	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000651	0.000871	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000651	0.000871	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.000649	0.000868	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000639	0.000856	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000637	0.000853	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD2—nicotine dependence	0.000636	0.000852	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—WASF2—nicotine dependence	0.000636	0.000851	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000632	0.000846	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000625	0.000836	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000621	0.000832	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000619	0.000828	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—WASF1—nicotine dependence	0.00061	0.000816	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000597	0.000799	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.000597	0.000799	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000592	0.000792	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000592	0.000792	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000584	0.000782	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.00058	0.000777	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000575	0.00077	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000571	0.000764	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000567	0.000759	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000564	0.000755	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	0.000549	0.000734	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000542	0.000725	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000534	0.000715	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.000527	0.000705	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000519	0.000694	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000518	0.000693	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.000513	0.000686	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000512	0.000685	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000511	0.000683	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000507	0.000679	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.000499	0.000668	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000492	0.000658	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000491	0.000657	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000478	0.00064	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000471	0.000631	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000471	0.00063	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.000471	0.00063	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000461	0.000617	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000461	0.000617	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.000445	0.000596	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.000443	0.000593	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000436	0.000584	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000431	0.000577	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000431	0.000576	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000428	0.000573	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000427	0.000571	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000424	0.000567	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000422	0.000565	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000418	0.00056	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000405	0.000542	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD2—nicotine dependence	0.000397	0.000531	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000388	0.00052	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.000384	0.000515	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000376	0.000504	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.000369	0.000494	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.00035	0.000468	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000333	0.000446	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD2—nicotine dependence	0.00032	0.000428	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000311	0.000417	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000306	0.00041	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD2—nicotine dependence	0.000278	0.000372	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000272	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000253	0.000338	CbGpPWpGaD
